| First Author | Jackson HW | Year | 2015 |
| Journal | PLoS One | Volume | 10 |
| Issue | 3 | Pages | e0120107 |
| PubMed ID | 25807548 | Mgi Jnum | J:229619 |
| Mgi Id | MGI:5752692 | Doi | 10.1371/journal.pone.0120107 |
| Citation | Jackson HW, et al. (2015) Timp3 deficient mice show resistance to developing breast cancer. PLoS One 10(3):e0120107 |
| abstractText | Timp3 is commonly silenced in breast cancer, but mechanistic studies have identified both tumor promotion and suppression effects of this gene. We have taken a genetic approach to determine the impact of Timp3 loss on two mouse models of breast cancer. Interestingly, MMTV-PyMT Timp3-- mice have delayed tumor onset and 36% of MMTV-Neu Timp3-- mice remain tumor free. TIMP3 is a regulator of TNF signaling and similar to Timp3, Tnf or Tnfr1 loss delays early tumorigenesis. The tumor suppression in Timp3 null mice requires Tnfr1, but does not result in alterations in the local immune compartment. In the mammary gland, Timps are highly expressed in the stroma and through the transplantation of tumor cells we observe that Timp3 deficiency in the host is sufficient to delay the growth of early, but not advanced tumor cells. Together our data is the first to identify a tumor promoting role of endogenous Timp3 in vivo, the spatial and temporal windows of this effect, and its dependence on Tnfr1. |
